We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
VDEC’s Discovery and Surveillance capabilities provide unique services across a spectrum of molecular immunology platforms
We use decades of experience in safe bioagent handling to support partners in research, development and testing of vaccines and therapeutics
VDEC works with global leaders from all sectors to develop and deliver the vaccine and therapeutic products we need to protect us from infectious diseases.
The Vaccine Development Evaluation Centre (VDEC) at Porton Down in Wiltshire facilitates the development and evaluation of new vaccines and therapeutics.
VDEC developed a standardised assay reduce the development of antimicrobial resistance and improve patient treatment for tuberculosis.
The pre-clinical evaluation team at VDEC provides a safe and controlled environment to test new vaccines and therapeutics before they progress to clinical trials
UKHSA offers a unique opportunity to harness world-class intellectual, scientific, and operational expertise for public health solutions
VDEC provides a number of services for vaccines post-licensure
See our science and technology working areas, and find out how to access our world-class specialist services and facilities.
The VDEC clinical evaluation team works to support vaccine and therapeutic development by providing expertise in immunological and functional assays used to support clinical trials (Phase I to IV)
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
From discovery to real-world impact, VDEC equips scientists with the expertise and facilities to navigate each step in the development of vaccines and therapeutics.
This series collates all documents relating to Rotavirus vaccination programme for infants
Information for the adult social care sector.
Data on the real-world efficacy of the COVID-19 vaccines.
Documents relating to the new coronavirus (COVID-19) vaccination programme.
Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
The UKHSA and NaTHNaC issue an annual reminder to those embarking on Hajj and Umrah journeys to be aware of infectious diseases in large gatherings.
A yearly overview of influenza surveillance results from the winter period.
Weekly national influenza and COVID-19 report, COVID-19 activity, seasonal flu and other seasonal respiratory illnesses.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).